SDAX gains 4 points at midday ahead of ECB decision

The SDAX stood at 18,426 points at 12:02 p.m. CET on October 29, 2026, up 4 points or 0.0 percent. European shares edged higher as markets awaited the European Central Bank's policy decision, Reuters reported.

Redcare Pharmacy reported third-quarter revenue growth of 18 percent to EUR 847 million. The company is a member of the SDAX, EQS via TradingView said.

Why is the SDAX holding near unchanged?

The index was only 4 points above its previous close at the latest timestamp. The broader European market was supported by earnings while investors waited for the ECB decision and comments from President Christine Lagarde.

The ECB was expected to keep its deposit rate at 2.50 percent. The refinancing rate was expected at 2.65 percent, XTB reported.

SDAX follows earnings and central banks

Redcare Pharmacy's revenue increased to EUR 847 million from EUR 719 million a year earlier. Its nine-month revenue reached EUR 2.55 billion, up 19 percent, according to EQS via TradingView.

What comes next for the SDAX

• October 29, 2026, 1:30 p.m. CET: US third-quarter GDP, September PCE inflation and jobless claims are due, with GDP expected at 3.2 percent and core PCE at 3.1 percent, CoinDesk reported.
• October 29, 2026, 2:15 p.m. CET: The ECB is scheduled to announce its interest-rate decision, followed by the press conference at 2:45 p.m. CET, European Central Bank said.

SDAX price data for October 29, 2026

The SDAX was at 18,426 points at 12:02 p.m. CET on October 29, 2026, up 4 points or 0.0 percent from the previous close. Deutsche Boerse's delayed market data showed 18,425.88 points and a 3.69-point gain, Deutsche Boerse reported.

More market reports and analysis on the SDAX